{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:49:41Z","timestamp":1787993381937,"version":"build-2784847793"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jvs.2023.01.195","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T12:40:26Z","timestamp":1675687226000},"page":"1742-1750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Outcome after revascularization with paclitaxel-coated devices in patients with chronic limb-threatening ischemia"],"prefix":"10.1016","volume":"77","author":[{"given":"Justin A.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine L.","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram S.","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae S.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Colvard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9500-413X","authenticated-orcid":false,"given":"Norman H.","family":"Kumins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2023.01.195_bib1","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa051303","article-title":"Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery","volume":"354","author":"Schillinger","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2023.01.195_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1583\/11-3627.1","article-title":"RESILIENT Investigators. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial","volume":"19","author":"Laird","year":"2012","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2023.01.195_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","article-title":"The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty","volume":"7","author":"Scheinert","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2023.01.195_bib4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2023.01.195_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2023.01.195_bib6","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2023.01.195_bib7","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","article-title":"Stellarex drug-coated balloon for treatment of femoropopliteal disease: twelve-month outcomes from the randomized ILLUMENATE pivotal and pharmacokinetic studies","volume":"136","author":"Krishnan","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2023.01.195_bib8","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jcin.2018.08.034","article-title":"Sustainable Antirestenosis effect with a low-dose drug-coated balloon: the ILLUMENATE European randomized Clinical trial 2-year results","volume":"11","author":"Brodmann","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2023.01.195_bib9","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(18)32262-1","article-title":"A\u00a0polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial","volume":"392","author":"Gray","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2023.01.195_bib10","doi-asserted-by":"crossref","first-page":"e005891","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891","article-title":"Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial","volume":"11","author":"Schneider","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2023.01.195_bib11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jconrel.2019.08.019","article-title":"Taking paclitaxel coated balloons to a higher level: predicting coating dissolution kinetics, tissue retention and dosing dynamics","volume":"310","author":"Tzafriri","year":"2019","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.jvs.2023.01.195_bib12","doi-asserted-by":"crossref","first-page":"e000117","DOI":"10.1136\/openhrt-2014-000117","article-title":"Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing","volume":"1","author":"Granada","year":"2014","journal-title":"Open Heart"},{"key":"10.1016\/j.jvs.2023.01.195_bib13","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jvs.2019.01.080","article-title":"Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease","volume":"70","author":"Caradu","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2023.01.195_bib14","doi-asserted-by":"crossref","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvs.2023.01.195_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ahj.2019.12.012","article-title":"Paclitaxel-related balloons and stents for the treatment of peripheral artery disease: insights from the Food and Drug Administration 2019 circulatory system devices panel meeting on late mortality","volume":"222","author":"Dan","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvs.2023.01.195_bib16","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1161\/CIRCULATIONAHA.119.044697","article-title":"Mortality and paclitaxel-coated devices: an individual patient data meta-analysis","volume":"141","author":"Rocha-Singh","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2023.01.195_bib17","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1161\/CIRCULATIONAHA.119.041099","article-title":"Paclitaxel-coated balloons and eluting stents: is there a mortality risk in patients with peripheral artery disease?","volume":"140","author":"Beckman","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2023.01.195_bib18","doi-asserted-by":"crossref","first-page":"e012523","DOI":"10.1161\/JAHA.119.012523","article-title":"Is paclitaxel causing mortality during lower-Extremity revascularization?","volume":"8","author":"Swaminathan","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvs.2023.01.195_bib19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jvs.2019.10.010","article-title":"Rigorous focus on paclitaxel-related mortality in femoropopliteal artery disease","volume":"71","author":"Ducasse","year":"2020","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2023.01.195_bib20","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.mayocp.2020.01.035","article-title":"Paclitaxel-coated balloons and stents for lower extremity peripheral arterial disease interventions: a regulatory perspective for the practicing clinician","volume":"95","author":"Vallabhajosyula","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jvs.2023.01.195_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jvs.2019.04.468","article-title":"Bursting the drug-eluting balloon bubble for femoropopliteal disease might be premature","volume":"70","author":"Joyce","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2023.01.195_bib22","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1056\/NEJMoa2005206","article-title":"Mortality with paclitaxel-coated devices in peripheral artery disease","volume":"383","author":"Nordanstig","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2023.01.195_bib23","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/15266028211023505","article-title":"Mortality rates after paclitaxel-coated device use in patients with occlusive femoropopliteal disease: an updated systematic review and meta-analysis of randomized controlled trials","volume":"28","author":"Dinh","year":"2021","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2023.01.195_bib24","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.jacc.2021.08.052","article-title":"Safety and Effectiveness of paclitaxel drug-coated devices in peripheral artery revascularization: Insights from VOYAGER PAD","volume":"78","author":"Hess","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2023.01.195_bib29","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jvs.2019.10.100","article-title":"Paclitaxel-coated peripheral artery devices are not associated with increased mortality","volume":"72","author":"Kumins","year":"2020","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2023.01.195_bib30","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ejvs.2019.12.034","article-title":"Editor's Choice - long term survival after femoropopliteal artery revascularisation with paclitaxel coated devices: a propensity score matched cohort analysis","volume":"59","author":"Behrendt","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2023.01.195_bib31","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jamacardio.2019.0325","article-title":"Association of survival with femoropopliteal artery revascularization with drug-coated devices","volume":"4","author":"Secemsky","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jvs.2023.01.195_bib32","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jvs.2021.05.035","article-title":"Paclitaxel-coated peripheral arterial devices are associated with improved overall survival and limb salvage in patients with chronic limb-threatening ischemia","volume":"74","author":"Kumins","year":"2021","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2023.01.195_bib33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/1526602820904783","article-title":"Mortality after paclitaxel-coated device use in patients with chronic limb-threatening ischemia: a systematic review and meta-analysis of randomized controlled trials","volume":"27","author":"Dinh","year":"2020","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2023.01.195_bib25","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/j.jacc.2019.02.020","article-title":"Drug-eluting stent implantation and long-term survival following peripheral artery revascularization","volume":"73","author":"Secemsky","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2023.01.195_bib26","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1016\/j.jcin.2021.08.058","article-title":"Vascular quality initiative surveillance of femoropopliteal artery paclitaxel devices","volume":"14","author":"Bertges","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2023.01.195_bib27","doi-asserted-by":"crossref","first-page":"e008528","DOI":"10.1161\/CIRCINTERVENTIONS.119.008528","article-title":"Mortality after paclitaxel coated balloon angioplasty and stenting of superficial femoral and popliteal artery in the Vascular Quality Initiative","volume":"13","author":"Bertges","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2023.01.195_bib28","doi-asserted-by":"crossref","first-page":"e018149","DOI":"10.1161\/JAHA.120.018149","article-title":"Survival and causes of death among Veterans with lower extremity revascularization with paclitaxel-coated devices: insights from the Veterans Health Administration","volume":"10","author":"Gutierrez","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvs.2023.01.195_bib34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jamacardio.2019.0198","article-title":"Evaluation of mortality data from the Social Security Administration death master file for clinical research","volume":"4","author":"Navar","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jvs.2023.01.195_bib35","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jvs.2019.05.034","article-title":"Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries","volume":"71","author":"Mohapatra","year":"2020","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2023.01.195_bib36","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jvs.2013.08.003","article-title":"The Society for vascular Surgery lower Extremity threatened limb classification System: risk stratification based on wound, ischemia, and foot infection (WIfI)","volume":"59","author":"Mills","year":"2014","journal-title":"J\u00a0Vasc Surg"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521423002793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521423002793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:28:08Z","timestamp":1777573688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521423002793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0741521423002793"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2023.01.195","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome after revascularization with paclitaxel-coated devices in patients with chronic limb-threatening ischemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2023.01.195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the Society for Vascular Surgery. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}